Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2026-01-16 @ 6:48 PM
Study NCT ID:
NCT06810895
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-02-06
First Post:
2024-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix
Sponsor:
Ding Ma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-10-27
First Submit QC Date:
None
Study First Post Date:
2025-02-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-01
Last Update Post Date:
2025-02-06
Last Update Post Date Type:
ACTUAL